Cipla receives US FDA approval for Generic Advair Diskus
Cipla and its wholly owned subsidiary Cipla USA announced that it has received US Food and Drug Administration (FDA) approval for…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Cipla
Six business lessons from Cipla’s nine-decade journey
Author Vijay Martis explains how Cipla's business model, strategy and purpose shaped its growth over nine decades
Cipla to acquire Inzpera Healthsciences for ₹110.65 Crore
Cipla Limited has announced that it will acquire a 100% stake in Inzpera Healthsciences for about ₹110.65 crore. Once completed,…
Eli Lilly and Cipla announce agreement to distribute and promote tirzepatide in India under the…
Cipla to distribute and promote Lilly’s tirzepatide as Yurpeak across India at the same price as Mounjaro, expanding access for…
AI compass: Transforming pharma commercialisation
As the world evolves at a rapid pace, pharma companies are embracing smarter approaches, leveraging AI across nearly every aspect…
Cipla invests in iCaltech Innovations to strengthen respiratory play
iCaltech is engaged in the design, development, and commercialisation of diagnostic medical equipment and apparatus, with a core…
ViiV Healthcare, Medicines Patent Pool extend voluntary licensing to enable access to HIV treatment
Through the agreement, the existing licensees, Aurobindo, Cipla and Viatris, will be able to develop, manufacture and supply…
Cipla appoints Prabhakaran Nair as Global Chief Manufacturing Officer
Nair to take charge from July 1, 2025; joins Cipla’s senior management with focus on global manufacturing and compliance
Cipla launches ZEMDRI (Plazomicin) in India, aims to tackle AMR
Plazomicin is a novel anti-microbial with demonstrated activity against multi-drug resistant (MDR) bacteria and clinical efficacy…
Cipla receives US FDA approval for generic version of Abraxane
Cipla secures final USFDA approval for Protein-bound Paclitaxel 100 mg/vial; launch planned in H1 FY26 in the US market